Esperion to Participate in Fireside Chat at the Bank of America...


Esperion Therapeutics, Inc. , the Lipid Management Company focused on developing and commercializing convenient, complementary, cost-effective once-daily, oral therapies for the treatment of patients with elevated low density lipoprotein cholesterol , today announced that president and chief executive officer, Tim M. Mayleben, will participate in an analyst-led fireside chat with investors at the Bank of America Merrill Lynch 2017 Healthcare Conference in Las Vegas, NV on Wednesday, May 17, 2017 at 3:40 p.m. Pacific Time/6:40 p.m. Eastern Time.



from Biotech News